MacroGenics
MGNX
#9452
Rank
NZ$0.22 B
Marketcap
NZ$3.58
Share price
-1.01%
Change (1 day)
40.81%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): NZ-$0.93

According to MacroGenics's latest financial reports the company's current EPS (TTM) is NZ-$1.04. In 2025 the company made an earnings per share (EPS) of NZ-$2.15 a decrease over its 2024 EPS that were of NZ-$1.95.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.93-56.75%
2025NZ-$2.1510.28%
2024NZ-$1.95613.33%
2023NZ-$0.27-92.31%
2022NZ-$3.56-42.14%
2021NZ-$6.1536.44%
2020NZ-$4.51-21.84%
2019NZ-$5.76-24.58%
2018NZ-$7.64675.93%
2017NZ-$0.99-68.05%
2016NZ-$3.08168.25%
2015NZ-$1.15-55%
2014NZ-$2.553400%
2013NZ-$0.07297-108.68%
2012NZ$0.8424.49%
2011NZ$0.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.30-224.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.36-5,519.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.71-3,149.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ-$5.66 443.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.81-274.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.25-892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$2.86 175.44%๐Ÿ‡บ๐Ÿ‡ธ USA